Search

Your search keyword '"Sharma, Bhupinder"' showing total 278 results
Start Over Author "Sharma, Bhupinder"
278 results on '"Sharma, Bhupinder"'

2. Validated machine learning tools to distinguish immune checkpoint inhibitor, radiotherapy, COVID-19 and other infective pneumonitis

Author

Hindocha, Sumeet, Hunter, Benjamin, Linton-Reid, Kristofer, George Charlton, Thomas, Chen, Mitchell, Logan, Andrew, Ahmed, Merina, Locke, Imogen, Sharma, Bhupinder, Doran, Simon, Orton, Matthew, Bunce, Catey, Power, Danielle, Ahmad, Shahreen, Chan, Karen, Ng, Peng, Toshner, Richard, Yasar, Binnaz, Conibear, John, Murphy, Ravindhi, Newsom-Davis, Tom, Goodley, Patrick, Evison, Matthew, Yousaf, Nadia, Bitar, George, McDonald, Fiona, Blackledge, Matthew, Aboagye, Eric, and Lee, Richard

Published
2024
Full Text
View/download PDF

5. A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications

Author

El-Sharkawi, Dima, Sud, Amit, Prodger, Catherine, Khwaja, Jahanzaib, Shotton, Rohan, Hanley, Brian, Peacock, Victoria, Peng, Ying Ying, Arasaretnam, Anita, Sharma, Sarkhara, Aldridge, Frances, Sharma, Bhupinder, Wotherspoon, Andrew, Cheung, Betty, De Lord, Corinne, Johnston, Rosalynd, Kassam, Shireen, Pettengel, Ruth, Linton, Kim, Greaves, Paul, Cook, Lucy, Naresh, Kikkeri N., Cwynarski, Kate, Eyre, Toby A., Chau, Ian, Cunningham, David, and Iyengar, Sunil

Published
2023
Full Text
View/download PDF

6. Imaging assessment of haematopoietic and lymphoid tumours : advancing methodologies and applications

Author

Sharma, Bhupinder, Harries, Priscilla, Jackson, Marcus, and Morgan, Robert

Subjects
cancer, lymphoma, imaging, radiology, scan, tomography, staging, haematological malignancy, haematological cancer, breast implant, Hodgkin's Lymphoma, Chronic Lymphocytic Leukaemia, Richter's transformation, stem cell transplantation, radiogenomics, Breast-implant Associated Anaplastic Large Cell Lymphoma, Treatment Response Assessment Maps, Contrast Clearance Analysis, Choline-PET
Abstract

Haematological malignancies are a burden being the fifth most common cancer and the second leading cause of cancer mortality on a global scale. Their presentation is complex due to disparate patterns of biological behaviour and anatomical involvement. Accurate detection of disease and precise assessment of treatment response is critical for optimal patient management. However, the appropriate use of imaging tests requires awareness of their strengths and limitations and appreciation of the myriad biological behaviours of haematological malignancies. This thesis presents research undertaken to enhance the imaging assessment of haematological malignancies. Four key themes of concern were identified and addressed. Firstly, general reporting of haematological malignancies lacked standardisation in staging, response, and prognostication assessment across all imaging studies: computed tomography (CT), positron emission tomography-computed tomography (PET-CT) and magnetic resonance imaging (MRI). A multimodality imaging report with a multidisciplinary team meeting (MDTM) style conclusion needs to be issued at each relevant timepoint in the patient pathway. The aim was to reduce imaging 'error' rates by using template reports, produce comparative datasets from different centres, and improve patient outcomes. Analogous to UK developments in pathology reporting, a robust and adaptable methodology, termed 'Specialist Integrated Haematological Malignancy Imaging Reporting' (SIHMIR), was formulated. Secondly, breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) imaging guidance varied widely. There was no detailed analysis of the strengths and weaknesses of the numerous imaging tests used, and patient data was prone to misinterpretation. No comprehensive imaging guidance was available for the distinct types of BIA-ALCL, a 'cascade' of investigations being performed. An assessment of the strengths and limitations of all anatomical and functional imaging investigations in BIA-ALCL was undertaken, and patient imaging pathways were developed. Thirdly, a prompt diagnosis of Richter's transformation (RT) from chronic lymphocytic leukaemia (CLL) was needed. The selection of a biopsy target to diagnose RT was a particular challenge in clinical practice. A PET-CT driven decision-making pathway to decide whether biopsy was required and, if so, to select a representative biopsy site in the era of novel therapies was developed. Lastly, MRI, used for central nervous system lymphoma (CNSL) imaging, was unable to differentiate disease activity from benign post-biopsy and inflammatory change and did not provide prognostic information. Two imaging applications for this purpose were developed: (i) the theoretical concept and clinical use of contrast clearance analysis (CCA), with its ability to differentiate viable CNSL from benign enhancement, and (ii) 18F-choline radiotracer (FCH) cranial PET-CT for staging, response-assessment, and prognostication. This thesis advances the imaging assessment in haematopoietic and lymphoid tumours, most notably with a standardised reporting framework (SIHMIR), guidance in both BIA-ALCL and CLL RT, and two CNSL imaging applications. The disease-histology specific approach to the use of imaging tests has been endorsed by the UK National Institute of Health and Care Excellence (NICE) Guidelines and UK Medicines and Healthcare products Regulatory Agency (MHRA) Guidelines. The new methodologies and tools described, particularly the two new tools for CNSL assessment, have the capacity to change global clinical and research trial practice.

Published
2022

11. COMPARISON OF FINE NEEDLE ASPIRATION CYTOLOGY, ZIEHL-NEELSEN STAINING AND CBNAAT IN SUSPECTED CASES OF TUBERCULAR LYMPHADENOPATHY.

Author

Garima, Kaur, Navneet, Singh, Harpal, Garg, Monika, Sharma, Bhupinder Kumar, and Goyal, Samriti

Subjects
NUCLEIC acid amplification techniques, EXTRAPULMONARY tuberculosis, NEEDLE biopsy, TURNAROUND time, PULMONOLOGY
Abstract

Objective: The objective of the study is to assess the usefulness of cytology, ZN staining and CBNAAT in diagnosis of suspected tubercular lymphadenopathy and to compare the results of cytology and ZN staining with CBNAAT findings in the diagnosis of suspected tubercular lymphadenopathy. Methods: The study was conducted on 100 patients with clinical suspicion of tubercular lymphadenopathy in Department of Pathology in collaboration with Department of Pulmonary Medicine, GMC, Patiala. The study was started after obtaining approval from the Institutional Ethics Committee. The records of suspected 100 EPTB patients who had under gone FNAC, ZN stain and CBNAAT test for EPTB diagnosis during the study period of 1 year were analysed. Results: The results shows male to female ratio of 1:1.4. The youngest patient was 28 days old and oldest was 77 years old. In this study, Granulomatous lymphadenopathy was the most predominant cytological finding (74%) followed by reactive lymphoid hyperplasia (16%), suppurative (08%), carcinomatous deposits (01%) and lymphoma (01%). Out of the total granulomatous lymphadenopathy i.e 74 cases, ZN stain was positive in 39 cases (52.7%) and CBNAAT was positive in 61 cases (82.4%). Out of the total 100 cases, all 39 ZN-positive cases were diagnosed with tuberculosis on FNAC. Among the 67 CBNAAT-positive cases, 61 were diagnosed with tuberculosis on FNAC, while 4 were diagnosed with suppurative lesions and 2 with reactive lymphoid hyperplasia. Conclusion: FNAC combined with CBNAAT emerged as a reliable diagnostic approach due to its rapid turnaround time and high sensitivity, facilitating early diagnosis and management of tubercular lymphadenopathy. [ABSTRACT FROM AUTHOR]

Published
2024

12. INCIDENTAL HISTOPATHOLOGICAL DIAGNOSIS OF TONSILLAR ACTINOMYCOSIS: 1 YEAR STUDY.

Author

Kaur, Kanwardeep, Kaur, Mohanvir, Garima, Sharma, Bhupinder Kumar, Kaur, Kushaldeep, and Harleen

Subjects
ACTINOMYCOSIS, MEDICAL personnel, METHENAMINE, TONSILLECTOMY, TONSILLITIS, PARAFFIN wax
Abstract

Actinomycosis in the tonsils is rare, despite the fact that the bacteria causing it are normally present in the mouth and throat and can colonize the tonsillar crypts, potentially leading to infection even in healthy individuals. Diagnosis is often incidental in tonsillectomy specimens sent to the pathology department for varied diseases. This study over the course of one year examined tonsillectomy samples and tonsillar biopsies that were initially diagnosed with chronic tonsillitis. The specimens were fixed in formalin, embedded in paraffin, and stained using various methods: haematoxylin and eosin (H&E) for general tissue structure, Gomori’s Methenamine Silver (GMS) to highlight fungal and certain bacterial elements, and Periodic Acid-Schiff (PAS) to identify polysaccharides and specific bacteria. The study aimed to detect actinomycosis in tonsillectomy specimens and tonsillar biopsies, as this infection is often found by chance. Using various staining techniques enhances the chances of identifying actinomycosis, which might be missed with routine methods. Accurate diagnosis and treatment depend on recognizing this infection, highlighting the importance of detailed histopathological examination. Out of 23 tonsillectomy specimens and tonsillar biopsies, four cases of tonsillar actinomycosis were identified. Histological examination revealed distinctive eosinophilic granules with peripheral radial projections, accompanied by microabscesses. Although tonsillar actinomycosis is commonly diagnosed incidentally, clinicians should maintain a high level of suspicion in cases of recurrent tonsillitis or unexplained tonsillar hypertrophy. [ABSTRACT FROM AUTHOR]

Published
2024

13. Contrast Clearance Analysis (CCA) to Assess Viable Tumour following Stereotactic Radiosurgery (SRS) to Brain Metastasis in Non-Small Cell Lung Cancer (NSCLC)

Author

Mohamedkhan, Shybi, primary, Hindocha, Sumeet, additional, de Boisanger, James, additional, Millard, Thomas, additional, Welsh, Liam, additional, Rich, Philip, additional, MacKinnon, Andrew D., additional, Williams, Nicholas, additional, Sharma, Bhupinder, additional, Rosenfelder, Nicola, additional, and Minchom, Anna, additional

Published
2024
Full Text
View/download PDF

15. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG)

Author

Turton, Philip, El-Sharkawi, Dima, Lyburn, Iain, Sharma, Bhupinder, Mahalingam, Preethika, Turner, Suzanne D., MacNeill, Fiona, Johnson, Laura, Hamilton, Stephen, Burton, Cathy, and Mercer, Nigel

Published
2021
Full Text
View/download PDF

16. Posterior reversible encephalopathy syndrome (PRES) in classic Hodgkin’s lymphoma, complicated by anthracycline-induced cardiomyopathy.

Author

Hall, Rose, Atmaja, Bambang, Sharma, Bhupinder, and Cunningham, David

Abstract

A woman in her 20s with no medical history was diagnosed with bulky stage II classic Hodgkin’s lymphoma after an 8-week history of shortness of breath, cough and lethargy. A regimen of doxorubicin (Adriamycin), bleomycin, vinblastine and dacarbazine (ABVD) was commenced with six cycles planned. During the first cycle, the patient was profoundly hypertensive. She then suffered two self-terminating tonic-clonic seizures. Examination and investigations diagnosed posterior reversible encephalopathy syndrome (PRES), which resolved completely in 11 days with strict blood pressure control and withholding chemotherapy. Treatment was further complicated by anthracycline-induced cardiomyopathy, requiring a switch in regimen to gemcitabine BVD. The patient made a full recovery from neurology and cardiology perspectives and completed six cycles of chemotherapy, achieving a complete metabolic response by the tumour. We illustrate the case, describe differential diagnoses and management of PRES, its association with chemotherapy and the successful chemotherapy rechallenge. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

17. A wolf in sheep's clothing: enteropathy associated T‐cell lymphoma involving a nasal polyp masquerading as primary mucosal CD30‐positive T‐cell lymphoproliferative disorder.

Author

Attygalle, Ayoma D, Vroobel, Katherine M, Madej, Ewelina, Tzioni, Maria‐Myrsini, Zhang, Chunye, Chen, Zi, Ribeiro, Sara, Calvachini, Silvia, Sharma, Bhupinder, Alexander, Emma J, Wotherspoon, Andrew C, and Du, Ming‐Qing

Subjects
T-cell lymphoma, LYMPHOPROLIFERATIVE disorders, NASAL polyps, INTESTINAL diseases, ANAPLASTIC large-cell lymphoma
Abstract

This article discusses a case study of an 81-year-old woman who presented with nose bleeds and a nasal polyp. The biopsy revealed features of anaplastic large-cell lymphoma (ALCL), but further testing showed that the diagnosis was actually enteropathy-associated T-cell lymphoma (EATL) involving the nasal polyp. The patient also had a history of coeliac disease (CD) and jejunal resection revealed EATL and refractory coeliac disease type 2 (RCD2). The article highlights the challenges in diagnosing and distinguishing between different types of lymphomas and emphasizes the importance of clinical correlation and awareness of relevant clinical details. The patient received treatment but unfortunately died 9 months after the initial presentation. [Extracted from the article]

Published
2024
Full Text
View/download PDF

20. CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial

Author

Gleeson, Mary, Peckitt, Clare, To, Ye Mong, Edwards, Laurice, Oates, Jacqueline, Wotherspoon, Andrew, Attygalle, Ayoma D, Zerizer, Imene, Sharma, Bhupinder, Chua, Sue, Begum, Ruwaida, Chau, Ian, Johnson, Peter, Ardeshna, Kirit M, Hawkes, Eliza A, Macheta, Marian P, Collins, Graham P, Radford, John, Forbes, Adam, Hart, Alistair, Montoto, Silvia, McKay, Pamela, Benstead, Kim, Morley, Nicholas, Kalakonda, Nagesh, Hasan, Yasmin, Turner, Deborah, and Cunningham, David

Published
2018
Full Text
View/download PDF

23. Outcomes of patients treated with RCHOP with a PET adapted approach for consolidative radiotherapy: a retrospective single centre study at the Royal Marsden hospital

Author

Li, Su, primary, Sharma, Bhupinder, additional, Yusuf, Siraj, additional, Michalarea, Vasiliki, additional, Gleeson, Mary, additional, Hickmott, Laura, additional, Wotherspoon, Andrew, additional, Attygalle, Ayoma D., additional, Vroobel, Katherine, additional, O'Connor, Simon, additional, Du, Yong, additional, Kuhnl, Andrea, additional, Iyengar, Sunil, additional, El-Sharkawi, Dima, additional, Chau, Ian, additional, and Cunningham, David, additional

Published
2023
Full Text
View/download PDF

26. Oncological Outcomes After Multidisciplinary Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).

Author

O'Connell, Rachel L., Sharma, Bhupinder, El-Sharkawi, Dima, Wotherspoon, Andrew, Attygalle, Ayoma D., MacNeill, Fiona, Khan, Aadil A., and Tasoulis, Marios-Konstantinos

Abstract

Introduction: Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon type of non-Hodgkin lymphoma, associated with breast implant capsules. Despite improvements in our understanding of BIA-ALCL, communicating the prognosis to patients remains challenging due to limited long-term follow-up data. This has important implications for decision-making, including recommendations for subsequent reconstructive procedures. The aim of this study was to assess the longer-term oncological outcomes of patients receiving multidisciplinary treatment for BIA-ALCL. Methods: This was a retrospective cohort study of BIA-ALCL patients treated at a tertiary referral unit. The data are presented using simple descriptive statistics. Results: Between 2015 and 2022, 18 BIA-ALCL patients were treated at our institution. The median age at diagnosis was 48.5 (IQR 41–55) years. Ten patients developed BIA-ALCL after cosmetic breast augmentation, and 8 after breast reconstruction following mastectomy for cancer. All patients had a history of textured implant insertion. The median time from first implant surgery to diagnosis was 8.5 (IQR 7–12) years. All patients underwent en-bloc total capsulectomy with implant removal, and 2 received systemic therapy. Fifteen patients had Stage I (IA–IC) disease, 2 had Stage IIA and 1 Stage III BIA-ALCL, based on the TNM classification system. At a median follow-up of 45 (IQR 15–71) months, there were no episodes of local or systemic relapse or death. Conclusions: Surgical management for BIA-ALCL is sufficient in early-stage disease, and associated with excellent oncological outcomes. This information is reassuring for patients when discussing recurrence risk. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

28. PARP inhibition utilized in combination therapy with Olaparib‐Temozolomide to achieve disease stabilization in a rare case of BRCA1‐mutant, metastatic myxopapillary ependymoma

Author

Mahalingam, Preethika, primary, Smith, Sam, additional, Lopez, Juanita, additional, Sharma, Rajaei K, additional, Millard, Thomas, additional, Thway, Khin, additional, Fisher, Cyril, additional, Reardon, David A, additional, Jones, Robin, additional, Nicholson, Andrew G, additional, Cunningham, David, additional, Welsh, Liam, additional, and Sharma, Bhupinder, additional

Published
2023
Full Text
View/download PDF

31. Autologous Transplantation in First Remission in the Rituximab Era in Patients with Mantle Cell Lymphoma: Experience from the Royal Marsden Hospital

Author

Mir, Farheen, primary, Robinson, Anna, additional, Ethell, Mark Edward, additional, Potter, Michael, additional, Nicholson, Emma, additional, Anthias, Chloe, additional, Easdale, Sandra, additional, Gonzalez-Arias, Carlos, additional, Sud, Amit, additional, Dearden, Claire E., additional, Chau, Ian, additional, Cunningham, David, additional, El-Sharkawi, Dima, additional, Sharma, Bhupinder, additional, and Iyengar, Sunil, additional

Published
2022
Full Text
View/download PDF

32. Does R-IPI Remain Predictive of Relapse Risk for Patients with DLBCL Achieving a Complete Remission with Frontline Therapy: Landmark Analysis of Two Large Prospective Clinical Trials

Author

El-Sharkawi, Dima, primary, Elnafie, Tasneem, additional, Thompson, Sarah, additional, Stanton, Louise, additional, Counsell, Nicholas, additional, Sud, Amit, additional, Chau, Ian, additional, Sharma, Bhupinder, additional, Johnson, Peter, additional, Linch, David C., additional, Iyengar, Sunil, additional, Davies, Andrew, additional, and Cunningham, David, additional

Published
2022
Full Text
View/download PDF

37. Cost and clinical benefit of imaging surveillance after treatment for breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)

Author

O'Connell, Rachel L., primary, Sharma, Bhupinder, additional, Van Kerckhoven, Liza, additional, Mehdi, Aia S., additional, Marshall, Chris, additional, Wotherspoon, Andrew, additional, Iyengar, Sunil, additional, E-Sharkawi, Dima, additional, Attygalle, Ayoma D., additional, Jurgensen-Rauch, Amanda, additional, Cunningham, David, additional, MacNeill, Fiona, additional, Khan, Aadil A., additional, and Tasoulis, Marios-Konstantinos, additional

Published
2021
Full Text
View/download PDF

40. [18F]Fluoromethylcholine PET/CT for CNS lymphoma assessment: a new tool

Author

Marshall, Kirsty, primary, Sharma, Bhupinder, additional, Millard, Thomas, additional, Chhabda, Sahil, additional, Sheikh, Fayed, additional, Guilhem, Emily, additional, Cunningham, Joel, additional, Du, Yong, additional, Alexander, Emma, additional, Cunningham, David, additional, Attygalle, Ayoma, additional, Chau, Ian, additional, Iyengar, Sunil, additional, and El-Sharkawi, Dima, additional

Published
2021
Full Text
View/download PDF

41. Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Cost Evaluation Study of Management and Surveillance, and Review of the Recent USA and UK Guidelines

Author

Mehdi, Aia S, primary, O'Connell, Rachel, additional, Potter, Michael, additional, Marshall, Chris, additional, Van Kerckhoven, Liza, additional, Iyengar, Sunil, additional, Nicholson, Emma, additional, El-Sharkawi, Dima, additional, Tasoulis, Marios, additional, Cunningham, David, additional, and Sharma, Bhupinder, additional

Published
2021
Full Text
View/download PDF

42. Immune Checkpoint Inhibitor and Radiotherapy-Related Pneumonitis: An Informatics Approach to Determine Real-World Incidence, Severity, Management, and Resource Implications

Author

Hindocha, Sumeet, primary, Campbell, Des, additional, Ahmed, Merina, additional, Giorgakoudi, Kyriaki, additional, Sharma, Bhupinder, additional, Yousaf, Nadia, additional, Molyneaux, Philip, additional, Hunter, Benjamin, additional, Kalsi, Hardeep, additional, Cui, Wanyuan, additional, Davidson, Michael, additional, Bhosle, Jaishree, additional, Minchom, Anna, additional, Locke, Imogen, additional, McDonald, Fiona, additional, O'Brien, Mary, additional, Popat, Sanjay, additional, and Lee, Richard W., additional

Published
2021
Full Text
View/download PDF

43. Can pre-transplant 18F-choline positron emission tomography predict relapse following autologous stem cell transplantation in primary central nervous system lymphoma?

Author

Millard, Thomas, primary, Sammour, Fatin, additional, Anthias, Chloe, additional, Easdale, Sandra, additional, Gonzalez-Arias, Carlos, additional, Ethell, Mark, additional, Potter, Mike, additional, Iyengar, Sunil, additional, El-Sharkawi, Dima, additional, Attygalle, Ayoma D., additional, Chau, Ian, additional, Cunningham, David, additional, Nicholson, Emma, additional, and Sharma, Bhupinder, additional

Published
2021
Full Text
View/download PDF

44. OAB-060: Prospective comparison of contemporary whole body MRI and FDG PET/CT for disease detection and correlation with markers of disease burden in myeloma: results of the iTIMM trial

Author

Kaiser, Martin, primary, Porta, Nuria, additional, sharma, Bhupinder, additional, Levine, Daniel, additional, Koh, Dow-Mu, additional, Boyd, Kevin, additional, Pawlyn, Charlotte, additional, Ridell, Angela, additional, Downey, Katherine, additional, Croft, James, additional, Bonner, Alison, additional, Morgan, Veronica, additional, Stern, Simon, additional, Jones, Lydia, additional, Cheung, Betty, additional, Kyriakou, Charalampia, additional, Kaczmarek, Pawel, additional, Winfield, jessica, additional, Blackledge, Matthew, additional, Oyen, Wim, additional, and Messiou, Christina, additional

Published
2021
Full Text
View/download PDF

46. Prospective Evaluation of Whole-Body MRI versus FDG PET/CT for Lesion Detection in Participants with Myeloma

Author

Messiou, Christina, primary, Porta, Nuria, additional, Sharma, Bhupinder, additional, Levine, Daniel, additional, Koh, Dow-Mu, additional, Boyd, Kevin, additional, Pawlyn, Charlotte, additional, Riddell, Angela, additional, Downey, Katherine, additional, Croft, James, additional, Morgan, Veronica, additional, Stern, Simon, additional, Cheung, Betty, additional, Kyriakou, Charalampia, additional, Kaczmarek, Pawel, additional, Winfield, Jessica, additional, Blackledge, Matthew, additional, Oyen, Wim J. G., additional, and Kaiser, Martin F., additional

Published
2021
Full Text
View/download PDF

48. Are treatment response assessment maps (TRAMs) and 18 F‐choline positron emission tomography the future of central nervous system lymphoma imaging?

Author

Kowa, Jie‐Ying, primary, Millard, Thomas, additional, Goldman, Anouchka, additional, Sharma, Rajaei K., additional, Attygalle, Ayoma, additional, Mahalingam, Preethika, additional, Marshall, Kirsty, additional, Welsh, Liam, additional, Li, Su, additional, Mackinnon, Andrew, additional, Rich, Philip, additional, Nicholson, Emma, additional, Iyengar, Sunil, additional, El‐Sharkawi, Dima, additional, Chau, Ian, additional, Cunningham, David, additional, and Sharma, Bhupinder, additional

Published
2021
Full Text
View/download PDF

50. Prospective comparison of whole body MRI and FDG PET/CT for detection of multiple myeloma and correlation with markers of disease burden: Results of the iTIMM trial.

Author

Kaiser, Martin F., primary, Porta, Nuria, additional, Sharma, Bhupinder, additional, Levine, Daniel, additional, Koh, Dow-Mu, additional, Boyd, Kevin, additional, Pawlyn, Charlotte, additional, Riddell, Angela M., additional, Downey, Kate, additional, Bonner, Alison, additional, Morgan, Veronica A, additional, Stern, Simon, additional, Jones, Lydia, additional, Cheung, Betty, additional, Kyriakou, Charalampia, additional, Kaczmarek, Pawel, additional, Winfield, Jessica Mary, additional, Blackledge, Matthew D., additional, Oyen, Wim J.G., additional, and Messiou, Christina, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results